Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Vabysmo
Pharma
Regeneron's Eylea franchise stumbles on several fronts in Q1
After consecutive setbacks at the FDA, Regeneron's string of recent troubles with its Eylea franchise is continuing to pull down the drugmaker.
Fraiser Kansteiner
Apr 29, 2025 2:50pm
FDA denies Regeneron's bid for dosage flexibility on Eylea
Apr 21, 2025 8:45am
FDA gives thumbs-up to Roche's Susvimo as treatment for DME
Feb 4, 2025 3:15pm
UK watchdog reaffirms Bayer's claims of misleading Roche promos
Jan 31, 2025 11:20am
Roche's Vabysmo crosses $4B mark as Polivy joins blockbuster club
Jan 30, 2025 11:06am
JPM25: Regeneron has few answers for declining sales of Eylea HD
Jan 14, 2025 10:25am
